GUARDANT HEALTH (Germany) Performance
| 5GH Stock | EUR 32.61 1.02 3.03% |
On a scale of 0 to 100, GUARDANT HEALTH holds a performance score of 11. The company owns a Beta (Systematic Risk) of 0.66, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, GUARDANT HEALTH's returns are expected to increase less than the market. However, during the bear market, the loss of holding GUARDANT HEALTH is expected to be smaller as well. Please check GUARDANT HEALTH's mean deviation, downside deviation, information ratio, as well as the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether GUARDANT HEALTH's current price history will revert.
Risk-Adjusted Performance
11 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in GUARDANT HEALTH CL are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, GUARDANT HEALTH reported solid returns over the last few months and may actually be approaching a breakup point. ...more
GUARDANT |
GUARDANT HEALTH Relative Risk vs. Return Landscape
If you would invest 2,303 in GUARDANT HEALTH CL on August 31, 2024 and sell it today you would earn a total of 958.00 from holding GUARDANT HEALTH CL or generate 41.6% return on investment over 90 days. GUARDANT HEALTH CL is currently producing 0.6286% returns and takes up 4.2094% volatility of returns over 90 trading days. Put another way, 37% of traded stocks are less volatile than GUARDANT, and 88% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GUARDANT HEALTH Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GUARDANT HEALTH's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GUARDANT HEALTH CL, and traders can use it to determine the average amount a GUARDANT HEALTH's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1493
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 5GH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.21 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.63 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average GUARDANT HEALTH is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GUARDANT HEALTH by adding it to a well-diversified portfolio.
GUARDANT HEALTH Fundamentals Growth
GUARDANT Stock prices reflect investors' perceptions of the future prospects and financial health of GUARDANT HEALTH, and GUARDANT HEALTH fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GUARDANT Stock performance.
| Return On Equity | -1.25 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (1.41) % | |||
| Operating Margin | (1.15) % | |||
| Shares Outstanding | 102.44 M | |||
| Revenue | 430.76 M | |||
| EBITDA | (462.23 M) | |||
| Cash And Equivalents | 1.79 B | |||
| Cash Per Share | 17.69 X | |||
| Total Debt | 1.35 B | |||
| Debt To Equity | 1.60 % | |||
| Book Value Per Share | 1.63 X | |||
| Cash Flow From Operations | (146.16 M) | |||
| Earnings Per Share | (3.92) X | |||
About GUARDANT HEALTH Performance
By analyzing GUARDANT HEALTH's fundamental ratios, stakeholders can gain valuable insights into GUARDANT HEALTH's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if GUARDANT HEALTH has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GUARDANT HEALTH has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. GUARDANT HEALTH operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 864 people.Things to note about GUARDANT HEALTH CL performance evaluation
Checking the ongoing alerts about GUARDANT HEALTH for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GUARDANT HEALTH CL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GUARDANT HEALTH CL appears to be risky and price may revert if volatility continues | |
| GUARDANT HEALTH CL has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 430.76 M. Net Loss for the year was (378.65 M) with profit before overhead, payroll, taxes, and interest of 250.74 M. | |
| GUARDANT HEALTH CL has accumulated about 1.79 B in cash with (146.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.69. | |
| Over 94.0% of the company shares are owned by institutions such as pension funds |
- Analyzing GUARDANT HEALTH's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GUARDANT HEALTH's stock is overvalued or undervalued compared to its peers.
- Examining GUARDANT HEALTH's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GUARDANT HEALTH's management team can have a significant impact on its success or failure. Reviewing the track record and experience of GUARDANT HEALTH's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GUARDANT HEALTH's stock. These opinions can provide insight into GUARDANT HEALTH's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for GUARDANT Stock analysis
When running GUARDANT HEALTH's price analysis, check to measure GUARDANT HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GUARDANT HEALTH is operating at the current time. Most of GUARDANT HEALTH's value examination focuses on studying past and present price action to predict the probability of GUARDANT HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GUARDANT HEALTH's price. Additionally, you may evaluate how the addition of GUARDANT HEALTH to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |